Rogobete, veste pentru pacienții cu mastocitoză sistemică: Au acces la tratamentul cu avapritinib

Former Health Minister Alexandru Rogobete announced that patients in Romania diagnosed with systemic mastocytosis now have access to avapritinib treatment following its reimbursement approval. He emphasized the importance of patient needs in healthcare decisions and highlighted that innovative treatments can significantly improve the quality of life for those with rare diseases. The approval came after discussions with patient representatives, including the president of the Romanian Mastocytosis Support Association. Rogobete views this decision as a step towards health reform, advocating for investments and modernization in the healthcare system.